MUN/2CL (MUN/2CL)

Munich Stock Exchange: MUN/2CL · EUR

€61.3

-0.09 (-0.1%)· Recorded snapshot

Market cap	12.2B
Revenue (ttm)	624.1M
Net income (ttm)	-605.6M
EPS (ttm)	-€3.21
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 624.1M
Net income (ttm): -605.6M
EPS (ttm): -€3.21
Market cap: 12.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.5P50 19.1P75 28.3

Trailing P/En/a

P25 14.1P50 23.7P75 38.5

ROEn/a

P25 -50.4P50 0.5P75 12

ROIC-63.1

P25 -29.8P50 1.9P75 10.7

Benchmarks · 1M

All MUN/2CL indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-29
Employees	1,001
Employees change	164
Employees growth	19.55%
Enterprise value	EUR 14.6B
Exchange	Munich Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2015
Industry	Biotechnology
Is primary listing	No
ISIN number	US10806X1028
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Market cap	EUR 12.2B
Next earnings date	2026-10-29
Price	EUR 61.27
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	mun/2CL
Website	https://bridgebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-4.64%
EV/Sales	22.75x
FCF / EV yield	-2.62%
FCF yield	-3.13%
P/S ratio	19.5x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-67.01%
EBITDA margin	-66.3%
Gross margin	94.44%
Operating margin	-67.01%
Pretax margin	-98.68%
Profit margin	-97.03%
Profit per employee	EUR -604,984
Revenue per employee	EUR 623,526
ROA	-26%
ROA (5Y)	-44.94%
ROCE	-146.28%
ROIC	-63.06%
SBC / revenue	20.65%
Tax / revenue	-0.23%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	0
Gross profit growth	196.87%
Gross profit growth (Q)	113.85%
Gross profit growth 3Y	505.13%
Gross profit growth 5Y	60.81%
Net income growth quarters	3
Net income growth years	0
Revenue growth	202.39%
Revenue growth (Q)	120.39%
Revenue growth (QoQ)	25.27%
Revenue growth 3Y	400.87%
Revenue growth 5Y	62.6%
Revenue growth quarters	5
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -888,430
Depreciation and amortization	EUR 4.6M
EBIT	EUR -418.2M
EBITDA	EUR -413.8M
EPS	EUR -3.21
Financing cash flow	EUR 348.4M
Free cash flow	EUR -381.1M
Free cash flow minus SBC	EUR -510M
Gross profit	EUR 589.4M
Income taxes	EUR -1.5M
Investing cash flow	EUR -30.4M
Net borrowing	EUR 540.6M
Net cash flow	EUR -62.2M
Net income	EUR -605.6M
Operating cash flow minus SBC	EUR -509.1M
Operating income	EUR -418.2M
Revenue	EUR 624.1M
Stock-based compensation	EUR 128.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.27
Book value per share	EUR -11.27
Interest coverage	-2.32
Long-term assets	EUR 82.9M
Long-term liabilities	EUR 2.5B
Net cash (debt)	EUR -2.3B
Net cash / market cap	-19.08%
Piotroski F-Score	2
Property, plant and equipment	EUR 20M
Shareholders' equity	EUR -2.2B
Tangible book value	EUR -2.2B
Tangible book value per share	EUR -11.39
Total assets	EUR 1.1B
Total cash	EUR 630.4M
Total debt	EUR 3B
Total liabilities	EUR 3.3B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.62
Current assets	EUR 982.6M
Current liabilities	EUR 800.6M
Current ratio	1.23
Inventory turnover	1.12
Net working capital	EUR 29.4M
Quick ratio	1.09
Working capital	EUR 177.2M
Working capital turnover	1.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.29%
Shareholder yield	-2.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 34.03
1D price change	-0.15%
1M price change	26.61%
1M total return	26.61%
1Y price change	100.96%
1Y return CAGR	101.06%
1Y total return	100.96%
20-day SMA	EUR 45.72
200-day SMA	EUR 38.70
3M price change	6.62%
3M total return	6.62%
3Y price change	121.08%
3Y return CAGR	30.26%
3Y total return	121.08%
50-day SMA	EUR 34.73
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 75.53
52-week high date	2026-07-13
52-week low	EUR 40.12
52-week low date	2025-08-26
5Y price change	47.71%
5Y return CAGR	8.12%
5Y total return	47.71%
6M price change	11.18%
6M total return	11.18%
All-time high	EUR 75.53
All-time high date	2026-07-13
All-time low	EUR 7.02
All-time low date	2022-05-06
Average true range (ATR)	EUR 5.52
Average volume	116.9
Change from 52-week high	-18.88%
Change from 52-week low	52.72%
Change from all-time high	-8.47%
Change from all-time low	884.2%
Change from open	0%
Day's gap	-0.15%
High price	EUR 61.27
Low price	EUR 61.27
Monthly RSI	66.95
Open price	EUR 61.27
Previous close	EUR 61.36
Price vs 150-day SMA	103.13%
Price vs 20-day SMA	51.19%
Price vs 200-day SMA	78.64%
Price vs 50-day SMA	99.08%
Relative volume	0.86
RSI	65.96
Sharpe ratio	1.36
Sortino ratio	2.49
Volume	0
Weekly RSI	72.98
YTD price change	11.18%
YTD total return	11.18%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	167.2M
Shares change (QoQ)	0.51%
Shares change (YoY)	2.29%
Shares held by insiders	3.93%
Shares held by institutions	87.78%
Short ratio	8.1 days

Deeper analysis on MUN/2CL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MUN/2CL report

Is a complete MUN/2CL research report available?

No complete published report is available for mun/2CL (MUN/2CL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MUN/2CL (MUN/2CL)

Price

Financial snapshot

Fair-value bridge

Latest news · MUN/2CL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MUN/2CL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MUN/2CL

Frequently asked questions